CCMH
FPRX

Cornerstone Capital Management Holdings’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$341K Sell
15,627
-11,400
-42% -$367K ﹤0.01% 1065
2017
Q3 		$1.1M Buy
27,027
+9,800
+57% +$308K 0.01% 907
2017
Q2 		$518K Buy
17,227
+494
+3% +$15.4K ﹤0.01% 1031
2017
Q1 		$604K Sell
16,733
-32,865
-66% -$1.45M ﹤0.01% 1023
2016
Q4 		$2.48M Buy
49,598
+525
+1% +$27.6K 0.02% 674
2016
Q3 		$2.58M Sell
49,073
-82,425
-63% -$3.94M 0.02% 677
2016
Q2 		$5.44M Buy
131,498
+50,100
+62% +$2.18M 0.04% 430
2016
Q1 		$3.31M Buy
81,398
+79,325
+3,827% +$2.73M 0.03% 583
2015
Q4 		$86K Sell
2,073
-327
-14% -$11K ﹤0.01% 1327
2015
Q3 		$37K Sell
2,400
-4,900
-67% -$105K ﹤0.01% 1434
2015
Q2 		$182K Buy
7,300
+2,100
+40% +$46.8K ﹤0.01% 1212
2015
Q1 		$119K Buy
+5,200
New +$131K ﹤0.01% 1250
2014
Q4 		– Sell
-3,000
Closed -$35K – 1342
2014
Q3 		$35K Buy
+3,000
New +$37.9K ﹤0.01% 1228

Other funds holding FPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Cornerstone Capital Management Holdings's FPRX Position: Q4 2017 in Review

Cornerstone Capital Management Holdings reduced its Five Prime Therapeutics, Inc. (FPRX) stake by 42% in Q4 2017, selling an estimated $367K and leaving 15,627 shares worth $341K. The position accounts for ﹤0.01% of the portfolio, ranked #1065.

Cornerstone Capital Management Holdings first reported a position in FPRX in Q3 2014 and has held it in 13 quarters since. The position peaked at $5.44M in Q2 2016. 137 funds tracked by Wall St. Rank hold FPRX as of Q4 2017.

  • Cornerstone Capital Management Holdings held 15,627 shares of Five Prime Therapeutics, Inc. worth $341K as of Q4 2017.
  • Cornerstone Capital Management Holdings sold 11,400 Five Prime Therapeutics, Inc. shares in Q4 2017, an estimated $367K.
  • Five Prime Therapeutics, Inc. made up ﹤0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #1065 holding.
  • Cornerstone Capital Management Holdings first reported a position in Five Prime Therapeutics, Inc. in Q3 2014 and has held it in 13 quarters since.
  • Cornerstone Capital Management Holdings's Five Prime Therapeutics, Inc. position peaked at $5.44M in Q2 2016.
  • 137 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.